The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur

Foong Ming Moy; Bulgiba, Awang
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p678
Academic Journal
Background: Metabolic Syndrome is associated with increased risk for type 2 diabetes and cardiovascular diseases. However, different diagnostic criteria have been recommended by different expert groups. In Malaysia, there is a lack of research comparing these different diagnostic criteria. Therefore, it is our aim to study the concordance between the IDF and the modified NCEP ATP III definitions of Metabolic Syndrome among a Malay cohort in Kuala Lumpur; and to demonstrate if all participants have the same cardiometabolic risks. Methods: This was an analytical cross sectional study. Ethics approval was obtained and informed consent was given by all participants. Anthropometric measurements, blood pressure, fasting blood glucose and lipid profile were taken following standard protocols. Results: Metabolic Syndrome was diagnosed in 41.4% and 38.2% participants using the modified NCEP and IDF criteria respectively. Among those diagnosed with Metabolic Syndrome by modified NCEP, 7.6% were missed by the IDF criteria. Participants diagnosed by the modified NCEP criteria had lower BMI and waist circumference but had higher cardiometabolic risks than those diagnosed with both criteria. Their blood pressure, glucose, total cholesterol and triglyceride were more adverse than the IDF group. This demonstrated that central obesity may not be a prerequisite for the development of increased cardiometabolic risks within this Malay cohort. Conclusion: Metabolic syndrome is common in this Malay cohort regardless of the criterion used. The modified NCEP ATP III criteria may be more suitable in diagnosis of metabolic syndrome for this Malay cohort.


Related Articles

  • Metabolic syndrome & Framingham Risk Score: Observations from a coronary angiographic study in Indian patients. Khanna, Roopali; Kapoor, Aditya; Kumar, Sudeep; Tewari, Satyendra; Garg, Naveen; Goel, Pravin K. // Indian Journal of Medical Research;Feb2013, Vol. 137 Issue 2, p295 

    Background & objectives: Metabolic syndrome (MS) is an important determinant of cardiovascular (CV) risk. Framingham Risk Scores (FRS) often underestimate the CV risk in Asians, younger patients and those with MS. Asians often develop coronary artery disease (CAD) at a younger age and also have...

  • Cardiometabolic interventions - focus on transcriptional regulators. Joshua T. Chai; Choudhury, Robin P. // European Journal of Cardiovascular Medicine;2013, Vol. 2 Issue 3, p212 

    Cardiovascular disease (CVD) remains the largest healthcare burden in the Western world; and the increasing prevalence of type II diabetes mellitus, at least partially driven by a trend in lifestyle changes associated with global economic development, is likely to fuel this CVD burden worldwide....

  • Factor analysis of metabolic syndrome using direct measurement of insulin resistance in Chinese with different degrees of glucose tolerance. Chung-Ze Wu; Jiunn-Diann Lin; Jer-Chuan Li; Fone-Ching Hsiao; Chang-Hsun Hsieh; Shi-Wen Kuo; Yi-Jen Hung; Chieh-Hua Lu; Chih-Tuseng He; Dee Pei // Indian Journal of Medical Research;Apr2008, Vol. 127 Issue 4, p336 

    Background & objectives: With the increasing prevalence of type 2 diabetes and cardiovascular disease in Taiwan, the understanding of metabolic syndrome (MetS) becomes more important. The purpose of this study was to investigate the clustering patterns of the risk variables of the MetS with...

  • Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies. Panadero, M. I.; González, M. C.; Herrera, E.; Bocos, C. // Endocrine, Metabolic & Immune Disorders - Drug Targets;Sep2009, Vol. 9 Issue 3, p219 

    Peroxisome proliferator-activated receptor alpha (PPAR??) regulates transcription of genes involved both in lipid and glucose metabolism as well as in inflammation. Fibrates are PPARα ligands used to normalize lipid and glucose parameters and exert antiinflammatory effects. In fact, fibrates...

  • A Prospective Study of Dairy Intake and the Risk of Type 2 Diabetes in Women. Song, Yiqing; Klevak, Anna; Liu, Simin; Manson, Joann E.; Choi, Hyon K.; Ford, Earl; Buring, Julie E. // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1579 

    OBJECTIVE -- Although studies have indicated that increased dairy intake may reduce risk of overweight and insulin resistance syndrome, data directly relating dairy intake to type 2 diabetes remain sparse. RESEARCH DESIGN AND METHODS -- We prospectively examined the associations between intake...

  • Does the Metabolic Syndrome Exist? Grundy, Scott M. // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1689 

    The article examines whether the well-established clustering of metabolic risk factors underlying both cardiovascular disease and type 2 diabetes deserve to be called a syndrome and, even if the metabolic syndrome can be accepted as a concept, whether the concept has matured enough to be...

  • The Metabolic Syndrome (Emperor) Wears No Clothes. Kahn, Richard // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1693 

    The article examines whether there is a biological basis for integration of the metabolic syndrome into concepts of insulin resistance, pre-diabetes, and type 2 diabetes. It infers that the presence of the syndrome is associated with a higher risk of diabetes or cardiovascular disease (CVD)....

  • Advancing drug therapy of the metabolic syndrome. Grundy, Scott M // Nature Reviews Drug Discovery;May2009, Vol. 8 Issue 5, p341 

    The metabolic syndrome — a group of factors that raise the risk of cardiovascular disease and type 2 diabetes — is increasingly common. How might the challenges of developing improved therapies to normalize these risk factors be approached?

  • Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Hayden, Melvin R.; Tyagi, Suresh C. // Nutrition & Metabolism;2004, Vol. 1, p10 

    Background: The topical role of uric acid and its relation to cardiovascular disease, renal disease, and hypertension is rapidly evolving. Its important role both historically and currently in the clinical clustering phenomenon of the metabolic syndrome (MS), type 2 diabetes mellitus (T2DM),...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics